Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation
Key facts
- Who runs it
- Institute of Liver and Biliary Sciences, India
- Where
- India1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 15 Dec 2023
- Ended
- 31 Jan 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Supervised aerobic and resistance exercises
- Dietary supplementation
- Record updated
- 24 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Voluntary adult patient (>18 years), decompensated chronic liver disease patients planned for LDLT, and Who pass the screening tests done in the OPD; Able to follow the introductory level exercises as per the protocol in the OPD without any adverse event; No drop in the spO2 less than 93% on a 6 minute walk test
Who cannot take part
- Patients on the following drugs-; Higher corticosteroid dose (>0.1mg/kg/day),; BCAA (Branched chain amino acids); Growth hormone, testosterone, SARMs,; Ghrelin agonists, myostatin antibodies,; Activin IIR antagonists, angiotensin converting enzyme inhibitors,; Espindolol (mixed beta agonist and antagonists), and; Fast skeletal muscle troponin activators
- Patients with a physical disability (upper or lower limb deformity/abnormality)
- Exercise intolerance or inability to follow exercise regime
- Patients who fail the screening tests
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this randomised clinical trial (open label) is to test the effect of supervised aerobic and resistance exercises in chronic liver disease patients being planned for living donor liver transplantation (LDLT). The main question it aims to answer are:
Read full original descriptionShow less
* If pre-operative supervised aerobic and resistance exercise for 4 weeks can improve the measures of frailty (Liver frailty index, Short physical performance battery, pulmonary function tests) in chronic liver disease patients being planned for LDLT. * Can this approach also translate into clinically significant benefits in the postoperative outcomes of LDLT.
Participants will be randomised into two groups receiving either
1. Standard medical therapy along with supervised aerobic and resistance exercises for 4 weeks. 2. Standard medical therapy. The two groups will be compared for progression of the measures of frailty ver the course of their participation as well as their post LDLT outcomes.
The 2 groups in the trial
- Exercise GroupTreatment being tested
Treatment: Supervised aerobic and resistance exercises and Dietary supplementation
- Dietary supplementationExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Supervised Aerobic and Resistance Exercises on Measures of Frailty in Chronic Liver Disease Patients Undergoing Living Donor Liver Transplantation- an Open Label Randomised Controlled Trial
- Record updated
- 24 August 2025